Keywords: ViiV Healthcare, HIV partnership, GlaxoSmithKline, Shionogi, Pfizer, Onwership change, Dolutegravir, Regulatory filings

Revised terms for ViiV Healthcare and Shionogi HIV partnership

Article | 30 October 2012

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) says that Healthcare, its HIV/AIDS joint venture with Pfizer, and Japanese drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in